TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC
TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC
Recruiting · NCT06676449 · Registry updated 2026-01-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, carcinoma of esophagus, digestive system disorder, digestive system neoplasm, esophageal disorder, neoplasm | Recruiting | Phase 3 | 2026-01-07 | NCT06676449 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Shanghai Cancer Center | Shanghai | China | 257 |